Alleviating Burden of Chronic Musculoskeletal Pain in the Emergency Department
NCT06077526 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-02-12
Summary
Chronic musculoskeletal pain (CMP) and lack of physical activity often co-exist, contributing to increased disability, non-communicable diseases (e.g., obesity, diabetes, hypertension), psychological comorbidity (e.g., anxiety and depression), and healthcare utilization and costs \[1-6\]. Many individuals with CMP seek assistance at emergency departments (ED). ED overuse has been an ongoing concern, with 1-in-5 Americans presenting to the ED at least once each year \[7\]. Of these visits, 24 million are for adults seeking help for chronic pain, with an additional 12 million due to exacerbations of an existing chronic pain condition \[8\]. In 2021, the fourth most common reason for seeking care in the ED related to a primary diagnosis involving the musculoskeletal system, with an estimated 9.5 million visits \[9\]. Most ED visits result in a 'treat and release' approach, potentially disrupting continuity of care and resulting in follow-up ED visits \[10\]. These ED visits for chronic pain are indicative of accessibility problems to community-based primary and preventative care, compounded by limited or no health insurance coverage \[10\]. Based on the Emergency Medical Treatment and Labor Act, EDs are required to stabilize all patients regardless of ability to pay \[10\]. To alleviate the burden of CMP on patients and EDs, improve access to quality healthcare, and mitigate initial and repeat ED visits, alternative options are required. Here we propose a novel group-based intervention involving pain education (PE) and physical activity (PA) implemented in CMP patients presenting to the ED of a community level hospital. The investigators will recruit 60 adults from a community hospital located in the Shenandoah Valley region of Virginia; participants will be randomized to either Pain Education and Active Knowledge (P.E.A.K.) Rx (24 sessions of group PE+ + PA) or usual care. Research assessments are conducted with both groups at study entry (baseline), 8-weeks, 3-months, and 6-months.
Conditions
Interventions
- BEHAVIORAL
-
P.E.A.K. Rx
Pain Education + Physical Activity Group Based Intervention
- OTHER
-
Usual Care
Participants will receive the community hospital's usual care.
Sponsors & Collaborators
-
Bridgewater College
lead OTHER
Principal Investigators
-
Michael Ray, DC, MSc · Bridgewater College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-13
- Primary Completion
- 2027-05-15
- Completion
- 2027-05-15
More Related Trials
-
Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients
NCT03301766 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
NCT06071936 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy Study Comparing Compounded Topical Pain Creams vs. Placebo for Treating Pain Symptoms
NCT02497066 ·Status: COMPLETED ·Phase: PHASE3
-
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).
NCT05620576 ·Status: COMPLETED ·Phase: PHASE2
-
Palmitoylethanolamide for Chronic Inflammatory Pain Conditions
NCT06273462 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
NCT06247813 ·Status: RECRUITING ·Phase: PHASE2
-
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
NCT06071988 ·Status: UNKNOWN ·Phase: PHASE3
-
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain
NCT05630196 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain
NCT05086289 ·Status: COMPLETED ·Phase: PHASE2
-
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NCT04795635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain
NCT04874636 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
NCT04707157 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain
NCT02460692 ·Status: COMPLETED ·Phase: PHASE2
-
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
NCT07285018 ·Status: RECRUITING ·Phase: PHASE2
-
Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury
NCT01112748 ·Status: COMPLETED ·Phase: PHASE4
-
Bonipar for Acute and Chronic Musculoskeletal Pain
NCT03471507 ·Status: COMPLETED ·Phase: PHASE2
-
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
NCT04678895 ·Status: RECRUITING ·Phase: PHASE2
-
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
NCT06420765 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain
NCT01043263 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
NCT06071949 ·Status: UNKNOWN ·Phase: PHASE3
-
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
NCT06438471 ·Status: RECRUITING ·Phase: PHASE1
-
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
NCT06071975 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Etoricoxib on Peripheral Hyperalgesia
NCT01088256 ·Status: TERMINATED ·Phase: PHASE2
-
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
NCT01564069 ·Status: COMPLETED